Delivery Order SPE2DB20D3103-SPE2DB25FQ1L7
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $40,455.90 by the Defense Logistics Agency (DLA) for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $21,649.76 for 1,000 tablets of Januvia 100 mg on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,516.43 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed price contract. This non-set-aside award was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. Januvia is a prescription medication used in diabetes management,...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,452.56 for 1,000 tablets of Januvia 100 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract is a firm fixed price, non-set-aside delivery order issued by the Defense Department's Medical Supply Chain organization. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply delivery under the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,996.64 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract covers the supply of Januvia 50 mg tablets in a quantity of 90 units, utilizing firm fixed-price pricing. This award was issued competitively with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,196.24 by the Defense Logistics Agency on August 21, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement with an ultimate completion date of August 22, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $3,843.87 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Januvia is an oral medication used in the treatment of type 2 diabetes, representing part of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- This is a $46,769.54 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,503,905 units of the prescription drug Januvia 100mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a variety of pharmaceutical and medical supplies to support military treatment...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1L7Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 90 tablets of Januvia 100 mg, valued at $13,040.09. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 5, 2025. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. Januvia is a prescription medication used in diabetes management, consistent with AmerisourceBergen's established portfolio of pharmaceutical products supplied to federal healthcare systems. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support Medical program utilizes such contracts to maintain critical pharmaceutical inventory for active duty personnel, veterans, and beneficiaries across the Military Health System.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 9/4/25 |